Bnp Paribas Financial Markets / GILD
Bnp Paribas Financial Markets’s Gilead Sciences Inc Position
Does Bnp Paribas Financial Markets own Gilead Sciences Inc (GILD)? Yes — 1.97M shares worth $274M (+0.13% of its 13F portfolio) as of Q1 2026, down from 2.93M shares the prior filed quarter.
Position Value
$274M
Q1 2026
Shares
1.97M
% of Portfolio
+0.13%
Quarters Held
30
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.97M | $274M | +0.13% |
| Q4 2025 | 2.93M | $360M | +0.16% |
| Q3 2025 | 1.81M | $201M | +0.11% |
| Q2 2025 | 2.02M | $223M | +0.13% |
| Q1 2025 | 3.23M | $362M | +0.21% |
| Q4 2024 | 3.55M | $328M | +0.18% |
| Q3 2024 | 2.84M | $238M | +0.16% |
| Q2 2024 | 2.92M | $201M | +0.16% |
| Q1 2024 | 2.07M | $152M | +0.13% |
| Q4 2023 | 1.79M | $145M | +0.16% |
| Q3 2023 | 1.00M | $75M | +0.10% |
| Q2 2023 | 1.39M | $107M | +0.13% |
| Q1 2023 | 1.11M | $92M | +0.13% |
| Q4 2022 | 1.29M | $111M | +0.17% |
| Q3 2022 | 664.1K | $41.0B | +0.07% |
| Q2 2022 | 919.0K | $56.8B | +0.09% |
| Q1 2022 | 1.12M | $66.3B | +0.09% |
| Q4 2021 | 1.51M | $109.5B | +0.16% |
| Q3 2021 | 1.76M | $123.2B | +0.17% |
| Q2 2021 | 2.47M | $170.2B | +0.23% |
| Q1 2021 | 1.27M | $81.9B | +0.12% |
| Q4 2020 | 798.3K | $46.5B | +0.09% |
| Q3 2020 | 2.58M | $163.3B | +0.23% |
| Q2 2020 | 1.37M | $105.3B | +0.19% |
| Q1 2020 | 2.64M | $197.5B | +0.41% |
| Q4 2019 | 1.20M | $77.8B | +0.14% |
| Q3 2019 | 1.80M | $114.1B | +0.20% |
| Q2 2019 | 2.01M | $135.6B | +0.27% |
| Q1 2019 | 1.98M | $128.5B | +0.28% |
| Q4 2018 | 1.91M | $119.7B | +0.28% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bnp Paribas Financial Markets’s full portfolio or all institutional holders of GILD.